You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 37 No. 1, January 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cerebral Ventricular Enlargement in Chronic Schizophrenia

An Association With Poor Response to Treatment

Daniel R. Weinberger, MD; Llewellyn B. Bigelow, MD; Joel E. Kleinman, MD; Susan T. Klein; Jack E. Rosenblatt, MD; Richard Jed Wyatt, MD

Arch Gen Psychiatry. 1980;37(1):11-13.


Abstract

• Response to neuroleptic drug treatment in ten chronic schizophrenic patients with enlarged cerebral ventricles was compared with ten similar patients with normal ventricles. The groups were closely matched for age, age at onset of illness, years of illness and hospitalization, drug dosage, and plasma neuroleptic concentration as measured by radioreceptor assay. Response was significantly worse in the patients with enlarged ventricles. This finding supports the notion that ventricular enlargement is clinically relevant in patients with chronic schizophrenia and that patients with this abnormality may have a biologically different illness than similar patients without it.



Author Affiliations

From the Laboratory of Clinical Psychopharmacology, Division of Special Mental Health Research, Intramural Research Program, National Institute of Mental Health, St Elizabeth's Hospital, Washington, DC.


Footnotes

Accepted for publication Aug 28, 1979.

Reprint requests to Laboratory of Clinical Psychopharmacology, Division of Special Mental Health Research, Intramural Research Program, National Institute of Mental Health, St Elizabeth's Hospital, Washington, DC 20032 (Dr Weinberger).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Selective Deficits in Prefrontal Cortex Function in Medication-Naive Patients With Schizophrenia
Barch et al.
Arch Gen Psychiatry 2001;58:280-288.
ABSTRACT | FULL TEXT  

Brain Anatomic Magnetic Resonance Imaging in Childhood-Onset Schizophrenia
Frazier et al.
Arch Gen Psychiatry 1996;53:617-624.
ABSTRACT  

Glutamate Receptor Dysfunction and Schizophrenia
Olney and Farber
Arch Gen Psychiatry 1995;52:998-1007.
ABSTRACT  

Is There a Neuroanatomic Basis for Schizophrenia? An Old Question Revisited
Benes
Neuroscientist 1995;1:104-115.
ABSTRACT  

Brain Morphology, Dopamine, and Eye-Tracking Abnormalities in First-Episode Schizophrenia: Prevalence and Clinical Correlates
Lieberman et al.
Arch Gen Psychiatry 1993;50:357-368.
ABSTRACT  

Time Course and Biologic Correlates of Treatment Response in First-Episode Schizophrenia
Lieberman et al.
Arch Gen Psychiatry 1993;50:369-376.
ABSTRACT  

Quantitative Cerebral Anatomy in Depression: A Controlled Magnetic Resonance Imaging Study
Coffey et al.
Arch Gen Psychiatry 1993;50:7-16.
ABSTRACT  

Pronounced Reduction of Total Neuron Number in Mediodorsal Thalamic Nucleus and Nucleus Accumbens in Schizophrenics
Pakkenberg
Arch Gen Psychiatry 1990;47:1023-1028.
ABSTRACT  

Structural Brain Abnormalities in Bipolar Affective Disorder: Ventricular Enlargement and Focal Signal Hyperintensities
Swayze et al.
Arch Gen Psychiatry 1990;47:1054-1059.
ABSTRACT  

Magnetic Resonance Imaging of the Brain in Schizophrenia: The Pathophysiologic Significance of Structural Abnormalities
Andreasen et al.
Arch Gen Psychiatry 1990;47:35-44.
ABSTRACT  

Ventricle-Brain Ratio, Computed Tomographic Density, and Brain Area in 50 Schizophrenics
Pearlson et al.
Arch Gen Psychiatry 1989;46:690-697.
ABSTRACT  

Cholinergic Hyperactivity and Negative Schizophrenic Symptoms: A Model of Cholinergic/Dopaminergic Interactions in Schizophrenia
Tandon and Greden
Arch Gen Psychiatry 1989;46:745-753.
ABSTRACT  

Quantitative Neuroanatomy in Schizophrenia: A Controlled Magnetic Resonance Imaging Study
Kelsoe et al.
Arch Gen Psychiatry 1988;45:533-541.
ABSTRACT  

Brain imaging: applications in psychiatry
Andreasen
Science 1988;239:1381-1388.
ABSTRACT  

Schizophrenia: is the concept disintegrating?
Murray and Foerster
J Psychopharmacol 1987;1:133-139.
 

Longitudinal Measurement of Plasma Homovanillic Acid Levels in Schizophrenic Patients: Correlation With Psychosis and Response to Neuroleptic Treatment
Pickar et al.
Arch Gen Psychiatry 1986;43:669-676.
ABSTRACT  

Atrophy Limited to the Third Ventricle in Chronic Schizophrenic Patients: Report of a Controlled Series
Boronow et al.
Arch Gen Psychiatry 1985;42:266-271.
ABSTRACT  

Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients
Pickar et al.
Science 1984;225:954-957.
ABSTRACT  

Regional Brain Glucose Metabolism in Chronic Schizophrenia: A Positron Emission Transaxial Tomographic Study
Farkas et al.
Arch Gen Psychiatry 1984;41:293-300.
ABSTRACT  

Brain Function in Psychiatric Disorders: I. Regional Cerebral Blood Flow in Medicated Schizophrenics
Gur et al.
Arch Gen Psychiatry 1983;40:1250-1254.
ABSTRACT  

CSF Dopamine {beta}-Hydroxylase in Schizophrenia: Low Activity Associated With Good Prognosis and Good Response to Neuroleptic Treatment
Sternberg et al.
Arch Gen Psychiatry 1983;40:743-747.
ABSTRACT  

Dopamine-beta-hydroxylase activity and homovanillic acid in spinal fluid of schizophrenics with brain atrophy
van Kammen et al.
Science 1983;220:974-977.
ABSTRACT  

Computed Tomography in Schizophrenics and Normal Volunteers: I. Fluid Volume
Jernigan et al.
Arch Gen Psychiatry 1982;39:765-770.
ABSTRACT  

Cerebral Ventricular Enlargement in Subtypes of Chronic Schizophrenia
Nasrallah et al.
Arch Gen Psychiatry 1982;39:774-777.
ABSTRACT  

Computed Tomography in Schizophreniform Disorder and Other Acute Psychiatric Disorders
Weinberger et al.
Arch Gen Psychiatry 1982;39:778-783.
ABSTRACT  

Computed Tomography in Schizophrenia: Disparities in the Prevalence of Abnormalities
Luchins
Arch Gen Psychiatry 1982;39:859-860.
ABSTRACT  

Schizophrenia: dopamine beta-hydroxylase activity and treatment response
Sternberg et al.
Science 1982;216:1423-1425.
ABSTRACT  

Plasma Prolactin Concentrations and Psychopathology in Chronic Schizophrenia
Kleinman et al.
Arch Gen Psychiatry 1982;39:655-657.
ABSTRACT  

Tardive Dyskinesia: Prevalence and Risk Factors, 1959 to 1979
Kane and Smith
Arch Gen Psychiatry 1982;39:473-481.
ABSTRACT  

Computed Tomography and Psychiatric Disorders
OVSIEW
ANN INTERN MED 1982;96:126-127.
ABSTRACT  

Increased Whole Blood Serotonin Concentrations in Chronic Schizophrenic Patients
DeLisi et al.
Arch Gen Psychiatry 1981;38:647-650.
ABSTRACT  

Cerebral Ventricular Enlargement and Dopamine Synthesis Inhibition in Chronic Schizophrenia
Nasrallah et al.
Arch Gen Psychiatry 1980;37:1427-1427.
ABSTRACT  

Psychiatry
Freedman
JAMA 1980;243:2208-2210.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.